Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...

Cannabidiol (CBD) is not recommended for glaucoma because research shows mixed effects on intraocular pressure (IOP), including possible increases that may worsen vision loss. Eye-related side effects ...

Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...

Glaucoma is one of the leading causes of visual impairment and blindness. According to statistics from the Hospital Authority, in Hong Kong, three out of every 100 individuals aged over 40 suffer from ...

Higher rates of glaucoma therapy seen at increasing IOP levels, with cutoff of 22 mm Hg influencing clinician decision-making. HealthDay News — Clinicians seem to generally use intraocular pressure ...

Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.

Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...

Machine learning accurately predicts peak and average IOP, aiding glaucoma management by informing treatment decisions. Random forest regression (RFR) outperformed ...

SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

The authors noted that this is the first prospective case series to apply a structured, protocol-based approach to ...

Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (IOP) daily. The current tools for IOP measurement are not portable, convenient, ...

LOVELAND, CO - January 27, 2026 - PRESSADVANTAGE - As awareness grows around early detection and management of ...